157 related articles for article (PubMed ID: 23868076)
1. The C-terminal half of the α2C-adrenoceptor determines the receptor's membrane expression level and drug selectivity.
Jahnsen JA; Uhlén S
Naunyn Schmiedebergs Arch Pharmacol; 2013 Dec; 386(12):1031-40. PubMed ID: 23868076
[TBL] [Abstract][Full Text] [Related]
2. A new, simple and robust radioligand binding method used to determine kinetic off-rate constants for unlabeled ligands. Application at α2A- and α2C-adrenoceptors.
Uhlén S; Schiöth HB; Jahnsen JA
Eur J Pharmacol; 2016 Oct; 788():113-121. PubMed ID: 27318322
[TBL] [Abstract][Full Text] [Related]
3. [3H]RS79948-197 binding to human, rat, guinea pig and pig alpha2A-, alpha2B- and alpha2C-adrenoceptors. Comparison with MK912, RX821002, rauwolscine and yohimbine.
Uhlén S; Dambrova M; Näsman J; Schiöth HB; Gu Y; Wikberg-Matsson A; Wikberg JE
Eur J Pharmacol; 1998 Feb; 343(1):93-101. PubMed ID: 9551719
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the first transmembrane segment of human α(2) -adrenoceptors in the subtype-selective binding of chlorpromazine, spiperone and spiroxatrine.
Laurila JM; Wissel G; Xhaard H; Ruuskanen JO; Johnson MS; Scheinin M
Br J Pharmacol; 2011 Nov; 164(5):1558-72. PubMed ID: 21649638
[TBL] [Abstract][Full Text] [Related]
5. α
Sánchez-Soto M; Casadó-Anguera V; Yano H; Bender BJ; Cai NS; Moreno E; Canela EI; Cortés A; Meiler J; Casadó V; Ferré S
Mol Neurobiol; 2018 Nov; 55(11):8438-8454. PubMed ID: 29552726
[TBL] [Abstract][Full Text] [Related]
6. Quantification of alpha2A and alpha2C adrenoceptors in the rat striatum and in different regions of the spinal cord.
Uhlén S; Lindblom J; Tiger G; Wikberg JE
Acta Physiol Scand; 1997 Aug; 160(4):407-12. PubMed ID: 9338523
[TBL] [Abstract][Full Text] [Related]
7. Selective increase of alpha2A-adrenoceptor agonist binding sites in brains of depressed suicide victims.
Callado LF; Meana JJ; Grijalba B; Pazos A; Sastre M; García-Sevilla JA
J Neurochem; 1998 Mar; 70(3):1114-23. PubMed ID: 9489732
[TBL] [Abstract][Full Text] [Related]
8. The affinity and selectivity of α-adrenoceptor antagonists, antidepressants and antipsychotics for the human α2A, α2B, and α2C-adrenoceptors and comparison with human α1 and β-adrenoceptors.
Proudman RGW; Akinaga J; Baker JG
Pharmacol Res Perspect; 2022 Apr; 10(2):e00936. PubMed ID: 35224877
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular effects of rilmenidine, moxonidine and clonidine in conscious wild-type and D79N alpha2A-adrenoceptor transgenic mice.
Zhu QM; Lesnick JD; Jasper JR; MacLennan SJ; Dillon MP; Eglen RM; Blue DR
Br J Pharmacol; 1999 Mar; 126(6):1522-30. PubMed ID: 10217548
[TBL] [Abstract][Full Text] [Related]
10. alpha2C adrenoceptors inhibit adenylyl cyclase in mouse striatum: potential activation by dopamine.
Zhang W; Klimek V; Farley JT; Zhu MY; Ordway GA
J Pharmacol Exp Ther; 1999 Jun; 289(3):1286-92. PubMed ID: 10336518
[TBL] [Abstract][Full Text] [Related]
11. Deletion of the α2A/α2C-adrenoceptors accelerates cutaneous wound healing in mice.
Romana-Souza B; Nascimento AP; Brum PC; Monte-Alto-Costa A
Int J Exp Pathol; 2014 Oct; 95(5):330-41. PubMed ID: 25186490
[TBL] [Abstract][Full Text] [Related]
12. Cooling evokes redistribution of alpha2C-adrenoceptors from Golgi to plasma membrane in transfected human embryonic kidney 293 cells.
Jeyaraj SC; Chotani MA; Mitra S; Gregg HE; Flavahan NA; Morrison KJ
Mol Pharmacol; 2001 Dec; 60(6):1195-200. PubMed ID: 11723226
[TBL] [Abstract][Full Text] [Related]
13. Reduced expression of alpha2C-adrenoceptors in rat striatum following antisense oligodeoxynucleotide infusion.
Lu L; Ordway GA
Brain Res Mol Brain Res; 1997 Jul; 47(1-2):267-74. PubMed ID: 9221925
[TBL] [Abstract][Full Text] [Related]
14. Expression and function of alpha-adrenoceptors in zebrafish: drug effects, mRNA and receptor distributions.
Ruuskanen JO; Peitsaro N; Kaslin JV; Panula P; Scheinin M
J Neurochem; 2005 Sep; 94(6):1559-69. PubMed ID: 16000146
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization and CNS effects of a novel highly selective alpha2C-adrenoceptor antagonist JP-1302.
Sallinen J; Höglund I; Engström M; Lehtimäki J; Virtanen R; Sirviö J; Wurster S; Savola JM; Haapalinna A
Br J Pharmacol; 2007 Feb; 150(4):391-402. PubMed ID: 17220913
[TBL] [Abstract][Full Text] [Related]
16. A study of presynaptic alpha2-autoreceptors in alpha2A/D-, alpha2B- and alpha2C-adrenoceptor-deficient mice.
Trendelenburg AU; Klebroff W; Hein L; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 2001 Aug; 364(2):117-30. PubMed ID: 11534851
[TBL] [Abstract][Full Text] [Related]
17. Actions of alpha2 adrenoceptor ligands at alpha2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for alpha2A adrenoceptors.
Newman-Tancredi A; Nicolas JP; Audinot V; Gavaudan S; Verrièle L; Touzard M; Chaput C; Richard N; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):197-206. PubMed ID: 9750005
[TBL] [Abstract][Full Text] [Related]
18. A PET Tracer for Brain α2C Adrenoceptors, (11)C-ORM-13070: Radiosynthesis and Preclinical Evaluation in Rats and Knockout Mice.
Arponen E; Helin S; Marjamäki P; Grönroos T; Holm P; Löyttyniemi E; Någren K; Scheinin M; Haaparanta-Solin M; Sallinen J; Solin O
J Nucl Med; 2014 Jul; 55(7):1171-7. PubMed ID: 24799619
[TBL] [Abstract][Full Text] [Related]
19. Alpha2-adrenoceptor regulation of adenylyl cyclase in CHO cells: dependence on receptor density, receptor subtype and current activity of adenylyl cyclase.
Pohjanoksa K; Jansson CC; Luomala K; Marjamäki A; Savola JM; Scheinin M
Eur J Pharmacol; 1997 Sep; 335(1):53-63. PubMed ID: 9371546
[TBL] [Abstract][Full Text] [Related]
20. Characterization of alpha2-adrenoceptor subtypes in pregnant human myometrium.
Adolfsson PI; Dahle LO; Berg G; Svensson SP
Gynecol Obstet Invest; 1998; 45(3):145-50. PubMed ID: 9565135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
